A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
Resource Type
Article
Authors
Hernando-Calvo, Alberto ; Han, Ming ; Ayodele, Olubukola ; Wang, Ben X. ; Bruce, Jeffrey P. ; Abbas-Aghababazadeh, Farnoosh ; Vila-Casadesús, Maria ; Sanz-Garcia, Enrique ; Yang, S.Y. Cindy ; Berman, Hal K. ; Vivancos, Ana ; Lam, Bernard ; Lungu, Ilinca ; Salawu, Abdulazeez ; Stayner, Lee-Anne ; Haibe-Kains, Benjamin ; Bedard, Philippe L. ; Avery, Lisa ; Razak, Albiruni R.A. ; Pugh, Trevor J. ; Spreafico, Anna ; Siu, Lillian L. ; Hansen, Aaron R.
Source
In Clinical Colorectal Cancer May 2024
Subject
Language
ISSN
1533-0028